Cytomegalovirus Retinitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2015-01-19
EMA Withdrawn: Vistide (cidofovir) — Gilead Sciences International Limited
Vistide (cidofovir) has been withdrawn from the European market by the marketing authorization holder Gilead Sciences International Limited.